Simplification / Commercialisation Clause Samples
The Simplification / Commercialisation clause is designed to streamline and clarify the terms of an agreement to ensure they are easily understood and commercially practical. In practice, this clause may require that contractual language be concise, avoid unnecessary legal jargon, and focus on the essential commercial terms relevant to the parties' business relationship. Its core function is to reduce ambiguity and complexity, making the contract more accessible and efficient for all parties involved, thereby minimizing misunderstandings and facilitating smoother business operations.
Simplification / Commercialisation. “In partnership with enterprise agencies and Interface…demonstrably simplified business access to the knowledge and expertise in Scottish universities”.
Simplification / Commercialisation. The University, in partnership with the Enterprise Agencies, Interface, and the Scottish HEI Sector strives to simplify business access to the knowledge and expertise in Scottish universities. Dundee participates in the UIF Enterprise Support Group (now a sub-group of US RCDG) and in the RCDG Contracts Sub-Group, both of which directly address this outcome. Dundee is recognised as a UK-leading university for commercialisation via commercial licensing and spin-out company formation. In 2021 it placed 6th in the UK in the University Spinout Report 2021 (Gorant), developing 1.5% of the UK’s spinouts with these companies raising £325.7 million over the past two decades, while in 2022 Dundee placed 4th in Beauhurst & Parkwalk “Equity Investment into UK Spin-outs”. These awards recognise outstanding success from companies such as Exscientia Ltd and Amphista Therapeutics Ltd , but also explicitly reference our entrepreneurial ecosystem (see also Outcome 4) We have made great strides over recent years in attracting investment from the global pharmaceutical industry – in 2020/21 our industry research income (HESA) rose to c. £15m. (around 20% of our total research income). We have also been able to invest commercially in Tay Therapeutics Ltd, one of our most high potential spin-outs, demonstrating the University’s commitment to this activity and to economic growth in our region. These successes depend on our continued commitment to deploying UIF in support of the ongoing activities of RIS, our Centre for Entrepreneurship (CfE) and School-based translational units such as the Drug Discovery Unit. We use the RCDG Contract Templates in all our dealings with Scottish-based industry partners and we have been progressively moving towards devolved standardised simple agreements (Non-Disclosure, Material Transfer, etc.) that can be signed off at School level thereby reducing transaction times for company partners. UIF will support our plans for 2022/23 and beyond in this area, including:
Simplification / Commercialisation. To simplify business access to the knowledge and expertise in Scottish universities.
Simplification / Commercialisation. In 2016 UWS developed three strategic themes around which it will focus teaching, research and enterprise activity: Sustainability, Health and Society. These themes have been a catalyst for cross disciplinary collaboration which is driving greater engagement with many of the Innovation Centres, Interface and with the Scottish Government’s proposed innovation reforms. UWS has had a particular focus on knowledge exchange in 2015/16, represented in part by our enhanced participation in schemes such as Knowledge Transfer Partnerships and Innovation Vouchers. From 15 to 16 UWS rose 20 places in the UK ranking table to be #3 in Scotland for KTP. In addition UWS accounted for 15% of the overall innovation voucher schemes run in Scotland which was 5% up on the previous year and ranked us among the top HEIs for the year. UWS sits on the Innovation Scotland Action Plan Implementation Group and is helping to lead the delivery of the important outcomes associated with this plan including a 16% increase in Start Ups in year One, the templating of contract types across all HEIs and the development of sector HEI liaison. • Target: We plan to continue this exceptional level of engagement and to maintain this grow level of 5% per annum. • Target: UWS is working towards a target of 15 start ups and spin outs by 2020
Simplification / Commercialisation. The plan for 2023/24 involves increasing core support for commercialisation. Targeting programs like iCure and the High Growth Spinout Programme will create a large opportunity pipeline. Over 2022/23, we have seen a notable improvement in our track record, demonstrating the effectiveness of our existing efforts. Building on this momentum, commercialisation opportunities will receive enhanced support from a scaled-up team including a group of high-profile EiRs and professional advisors. Increased resource from the UIF uplift will result in greater market engagement, enhancing commercialisation opportunities and strengthening industry partnerrships. Simplified university processes, bolstered resources and strong project management will ensure opportunities are optimally developed to align with the needs of the early-stage entrepreneurs and new ventures. Through these targeted efforts, a more supportive environment for commercialisation will be realised, ultimately contributing to the growth and success of high-potential ventures. Through consultations with Tech Scaler, Scotland's Chief Entrepreneur, SFC, and enterprise agencies, we will offer guidance on the 'Framework for Change,' aiming to incentivise universities to deliver quality commercialisation outcomes. The Business & Enterprise consistently strive to align program goals with economic development metrics used by Scottish Enterprise, Highlands and Islands Enterprise, and South of Scotland Enterprise.